| Name | TTN antisense RNA 1 |
| Description | This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nTTN‐AS1 is a long noncoding RNA whose aberrant expression is frequently observed in a broad range of malignancies, including esophageal squamous cell carcinoma, cervical cancer, papillary thyroid cancer, gastric cancer, lung adenocarcinoma, prostate cancer, cholangiocarcinoma, skin cutaneous melanoma, triple‐negative breast cancer, hepatocellular carcinoma, oral squamous cell carcinoma, and pancreatic cancer. In these cancers, TTN‐AS1 is typically upregulated and associated with advanced clinical stage, enhanced proliferation, migration, invasion, epithelial–mesenchymal transition, and metastasis that ultimately portend poor patient prognosis. Mechanistically, TTN‐AS1 generally functions as an oncogenic competing endogenous RNA by sponging a variety of tumor‐suppressive microRNAs (e.g., miR‐133b, miR‐142‐5p, miR‐573, miR‐320a, miR‐376b‐3p, miR‐139‐5p, miR‐199a‐3p, and miR‐513a‐5p), thereby modulating the expression of numerous key oncogenic effectors—including transcription factors, cell cycle regulators, and mediators of EMT (such as Snail1, FSCN1, CDK5, E2F3, neuropilin‐1, KLF12, PTEN, SPOCK1, PAK3, RUNX1, SFN, and SQLE)."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn contrast, TTN‐AS1 exhibits context‐dependent behavior in certain cancers. For example, in ovarian cancer, TTN‐AS1 expression is downregulated, and its overexpression suppresses tumor proliferation and colony formation while promoting apoptosis through a mechanism involving the miR‐15b‐5p/FBXW7 axis. Moreover, in large intestine cancer, TTN‐AS1 is induced following radiation exposure and contributes to radioresistance by downregulating miR‐134‐5p, which leads to increased levels of PAK3 and P21 and activation of the AKT/GSK‐3β/β‐catenin pathway. Preliminary investigations in gallbladder carcinoma also implicate TTN‐AS1 in tumor progression, and a meta‐analysis consolidates its overall prognostic significance across diverse malignancies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "15", "end_ref": "18"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nEmerging evidence further expands the functional repertoire of TTN‐AS1. In skin cutaneous melanoma, TTN‐AS1 facilitates tumorigenesis and metastasis by epigenetically upregulating its sense transcript, TTN, through both enhanced promoter activity and increased mRNA stability. In addition, TTN‐AS1 can be preferentially sorted into exosomes, suggesting a role in mediating intercellular communication within the tumor microenvironment. Collectively, these multifaceted, context‐dependent functions underscore the potential of targeting the TTN‐AS1/miRNA/target regulatory axis as a promising diagnostic and therapeutic strategy in cancer management."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "19"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Chenyu Lin, Shengnan Zhang, Ying Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional Role of a Novel Long Noncoding RNA "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "TTN-AS1"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " in Esophageal Squamous Cell Carcinoma Progression and Metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-17-1851"}], "href": "https://doi.org/10.1158/1078-0432.CCR-17-1851"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29101304"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29101304"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Ping Chen, Rui Wang, Qingfen Yue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA TTN-AS1 promotes cell growth and metastasis in cervical cancer via miR-573/E2F3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.08.077"}], "href": "https://doi.org/10.1016/j.bbrc.2018.08.077"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30135013"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30135013"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Zhenghui Cui, Zhiyan Luo, Zimei Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gene Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jgm.3083"}], "href": "https://doi.org/10.1002/jgm.3083"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30811764"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30811764"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "M M Dong, S J Peng, Y N Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA TTN-AS1 contributes to gastric cancer progression by acting as a competing endogenous RNA of miR-376b-3p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasma (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4149/neo_2018_180927N721"}], "href": "https://doi.org/10.4149/neo_2018_180927N721"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30943745"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30943745"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Jiwen Luo, Zheng Liu "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA TTN-AS1 promotes the progression of lung adenocarcinoma by regulating PTEN/PI3K/AKT signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2019.04.050"}], "href": "https://doi.org/10.1016/j.bbrc.2019.04.050"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31027732"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31027732"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yunlong Jia, Yuqing Duan, Tianxu Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-019-1811-y"}], "href": "https://doi.org/10.1038/s41419-019-1811-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31363080"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31363080"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "J-F Luo, J Xu, J-Z Zheng "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA TTN-AS1 promotes cell proliferation and inhibits cell apoptosis in prostatic cancer by sponging miR-193a-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201909_18991"}], "href": "https://doi.org/10.26355/eurrev_201909_18991"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31599406"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31599406"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Huaqiang Zhu, Bo Zhai, Changjun He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA TTN-AS1 promotes the progression of cholangiocarcinoma via the miR-320a/neuropilin-1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-020-02896-x"}], "href": "https://doi.org/10.1038/s41419-020-02896-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32801339"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32801339"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Ying Wang, Dongping Li, Jiqiang Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA TTN-AS1 facilitates tumorigenesis and metastasis by maintaining TTN expression in skin cutaneous melanoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-020-02895-y"}], "href": "https://doi.org/10.1038/s41419-020-02895-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32820147"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32820147"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Erhu Sun, Xiaofeng Liu, Cheng Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non‑coding RNA TTN‑AS1 regulates the proliferation, invasion and migration of triple‑negative breast cancer by targeting miR‑211‑5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2020.11683"}], "href": "https://doi.org/10.3892/mmr.2020.11683"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33179096"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33179096"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Xinghao Zhu, Shiqing Jiang, Zongyao Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.1882133"}], "href": "https://doi.org/10.1080/21655979.2021.1882133"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33517826"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33517826"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Zhongzhi Jin, Shengjun Jiang "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA TTN-AS1/microRNA-199a-3p/runt-related transcription factor 1 gene axis regulates the progression of oral squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.1982324"}], "href": "https://doi.org/10.1080/21655979.2021.1982324"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34606420"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34606420"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Yang Liu, Jiangyang Sun, Peng Qi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA titin-antisense RNA1 contributes to growth and metastasis of cholangiocarcinoma by suppressing microRNA-513a-5p to upregulate stratifin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.2011014"}], "href": "https://doi.org/10.1080/21655979.2021.2011014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34903127"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34903127"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Shuhui Wang, Lei Dong, Lin Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SQLE facilitates the pancreatic cancer progression via the lncRNA-TTN-AS1/miR-133b/SQLE axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.17347"}], "href": "https://doi.org/10.1111/jcmm.17347"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35638462"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35638462"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Sheng Miao, Jia Wang, Lili Xuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA TTN-AS1 acts as sponge for miR-15b-5p to regulate FBXW7 expression in ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biofactors (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/biof.1622"}], "href": "https://doi.org/10.1002/biof.1622"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32049388"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32049388"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Zhenkui Zuo, Shuling Ji, Lulu He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA TTN-AS1/miR-134-5p/PAK3 axis regulates the radiosensitivity of human large intestine cancer cells through the P21 pathway and AKT/GSK-3β/β-catenin pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biol Int (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cbin.11436"}], "href": "https://doi.org/10.1002/cbin.11436"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32749739"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32749739"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Zhaoxia Lin, Yaosheng Li, Rongfeng Shao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA TTN-AS1 acts as a tumor promoter in gallbladder carcinoma by regulating miR-107/HMGA1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "World J Surg Oncol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12957-021-02279-2"}], "href": "https://doi.org/10.1186/s12957-021-02279-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34090483"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34090483"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Guangyao Lin, Xiyu Liu, Chao Cong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostic significance of long noncoding RNA TTN-AS1 in various malignancies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Rep (Hoboken) (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cnr2.1876"}], "href": "https://doi.org/10.1002/cnr2.1876"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37528740"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37528740"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Xu Zhou, Xiaohan Kong, Jun Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating tumor cell-derived exosome-transmitted long non-coding RNA TTN-AS1 can promote the proliferation and migration of cholangiocarcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Nanobiotechnology (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12951-024-02459-8"}], "href": "https://doi.org/10.1186/s12951-024-02459-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38637832"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38637832"}]}]}]}
|
| NCBI Gene ID | 100506866 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
TTN-AS1 has 833 functional associations with biological entities spanning 4 categories (organism, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 13 datasets.
Click the + buttons to view associations for TTN-AS1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of TTN-AS1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of TTN-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of TTN-AS1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TTN-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TTN-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of TTN-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of TTN-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of TTN-AS1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TTN-AS1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of TTN-AS1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of TTN-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of TTN-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of TTN-AS1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |